603880 Jiangsu Nanfang Medical
- 4.01
- +0.02+0.50%
Jiangsu Nanfang Medical News
Express News | Jiangsu Nanfang Medical has received the 'Administrative Punishment Decision' issued by the Jiangsu Securities Regulatory Bureau.
Express News | ST Nanwei: Other risk warnings have been implemented for the company's shares
Express News | ST Nanwei: The company and actual controller Li Ping were administratively punished by the Securities Regulatory Commission for allegedly breaking the law and regulations on credit disclosure
ST Nanwei (603880.SH) announced first-quarter results, net profit of 1.75 million yuan, a year-on-year decrease of 74.82%
ST Nanwei (603880.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 1.3 during the reporting period...
ST Nanwei (603880.SH) announced 2023 annual results with a net loss of 147 million yuan
According to the Zhitong Finance App, ST Nanwei (603880.SH) disclosed the 2023 annual report. The company achieved revenue of 600 million yuan in 2023, an increase of 10.03%; net profit loss to mother was 147 million yuan, an increase over the previous year; loss after deducting non-net profit of 147 million yuan, a year-on-year increase; and basic earnings per share were -0.51 yuan. During the reporting period, the company's main business revenue increased slightly compared to last year; the decrease in net profit attributable to the parent company was mainly due to an oversupply of protective equipment, and price competition was intense; credit impairment losses and asset impairment losses increased.
ST Nanwei (603880.SH): There is no business involved in the AI medical field yet
Gelonghui, March 19丨ST Nanwei (603880.SH) said on the investor interactive platform that the company has no business involved in the AI medical field yet.
ST Nanwei (603880.SH): Shareholder Xu Dong has purchased 1.5565 million shares of the company
Gelonghui, Feb. 20 | ST Nanwei (603880.SH) announced that today the company received a notice from Mr. Xu Dong, a shareholder of more than 5%: As of February 20, 2024, Mr. Xu Dong had purchased 1,056,500 shares of the company through self-funded centralized bidding transactions in the secondary market. All proceeds from this share repurchase are owned by the listed company.
Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
The Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) share price has fared very poorly over the last month, falling by a substantial 28%. The drop over the last 30 days has capped off a tough year f
ST Nanwei (603880.SH): Jiangsu Securities Regulatory Bureau takes corrective regulatory measures against shareholder Xu Dong
ST Nanwei (603880.SH) issued an announcement. Recently, Xu Dong, a shareholder of more than 5% of the company, received the Jiangsu Securities Regulatory Bureau...
ST Nanwei (603880.SH) shareholder Xu Dong reduced the company's holdings by a total of 1,056,500 shares, and terminated the reduction in holdings early
ST Nanwei (603880.SH) issued an announcement. On December 15, 2023, the company received shareholder Xu Dong's “...
ST Nanwei (603880.SH) released the first three quarter results, net profit of 7.2626 million yuan, up 17.87% year on year
ST Nanwei (603880.SH) released its report for the first three quarters of 2023, with revenue of 470 million yuan, compared to the same period last year...
ST Nanwei (603880.SH) released first-half results, net profit of 7.904 million yuan, an increase of 26.67% over the previous year
ST Nanwei (603880.SH) released the 2023 semi-annual report. The company's revenue was 353 million yuan,...
ST Nanwei (603880.SH) director Xiang Qinhua reduced his holdings of the company by a total of 54,000 shares
ST Nanwei (603880.SH) issued an announcement. As of the announcement date, director Xiang Qinhua had reduced...
ST Nanwei: The Securities Regulatory Commission filed a case against the company for suspected information disclosure violations
On July 28丨ST Nanwei announced that the company received the “Notice of Case Filing” issued by the China Securities Regulatory Commission. Mr. Li Ping, the controlling shareholder and actual controller of the company, received a “Notice of Case Filing” from the China Securities Regulatory Commission on the same day. Because the company and Mr. Li Ping were suspected of illegal information disclosure violations, the China Securities Regulatory Commission decided to file a case against the company and Mr. Li Ping in accordance with laws and regulations such as the “Securities Law of the People's Republic of China” and “Administrative Penalty Law of the People's Republic of China”.
Li Ping, the controlling shareholder of ST Nanwei (603880.SH), plans to transfer 8% of the company's shares to Ren Weiguo to cash out 99.92 million yuan
According to the Zhitong Finance App, ST Nanwei (603880.SH) announced that Li Ping, the controlling shareholder of the company, plans to transfer the company's 23.4 million shares (about 8% of the company's total share capital) of unrestricted tradable shares to Ren Weiguo. The transfer price is 4.27 yuan/share, and the total transfer price (tax included) totals RMB 999.18 million. After the transfer of this agreement was completed, Li Ping's shareholding ratio of the company decreased from 40.63% to 32.63%, and Ren Weiguo's shareholding ratio reached 8%.
ST Nanwei (603880.SH): Xu Dong plans to reduce his shares by no more than 6%
On July 18丨ST Nanwei (603880.SH) announced that within 6 months after 15 trading days from the date of disclosure of this announcement, Mr. Xu Dong plans to reduce the number of shares held by no more than 5,849,480 shares through centralized bidding, that is, no more than 2% of the company's total shares. Within 6 months after 3 trading days from the date of disclosure of this announcement, Mr. Xu Dong plans to reduce the number of shares held by no more than 11,698,960 shares through bulk transactions, that is, no more than 4% of the company's total shares.
Xu Dong, the main shareholder of ST Nanwei (603880.SH), reduced his holdings by 1,8559 million shares
According to the Zhitong Finance App, ST Nanwei (603880.SH) announced that Xu Dong, a shareholder holding more than 5% of the company's shares, has reduced his holdings by 1,8559 million shares through centralized bidding transactions, accounting for 0.63% of the company's total share capital. The implementation period of the holdings reduction plan has ended, and the implementation of the holdings reduction plan has been completed.
ST Nanwei (603880.SH): Controlling shareholder Li Ping reduced his holdings by 2.8% in total, and the implementation of the share holdings reduction was completed
Gelonghui, June 20, 丨 ST Nanwei (603880.SH) announced that Li Ping, the controlling shareholder of the company, reduced his holdings by 5.44 million shares through bulk transactions, accounting for 1.86% of the company's total share capital, and reduced his holdings by 2.744 million shares through centralized bidding, accounting for 0.94% of the company's total share capital. The term of the current holdings reduction plan has expired, and the implementation of the holdings reduction plan has been completed.
ST NANWEI (603880.SH) terminates planning control changes
According to the Zhitong Finance App, ST Nanwei (603880.SH) announced that Li Ping, the controlling shareholder and actual controller of the company, previously proposed to change the controlling shareholder of the listed company to Suzhou Fengruida Optoelectronics Technology Co., Ltd. (“Suzhou Fengruida” for short) using a plan combining agreement transfer, waiver of voting rights, and issuance of A-shares by the listed company to specific targets. On June 15, 2023, the company and Suzhou Fengruida confirmed the subsequent arrangements for issuing shares to specific targets. Suzhou Fengruida was unable to provide definitive arrangements and relevant supporting information for this fixed capital increase. The two parties agreed to terminate the planning
ST NANWEI: Stop planning this control change
Gelonghui, June 15, 丨 ST Nanwei announced that the company and Suzhou Fengruida have confirmed the subsequent arrangements for issuing shares to specific targets. Suzhou Fengruida was unable to provide definitive arrangements for this fixed capital increase and relevant supporting information. Following a consensus decision between the two parties, the two parties decided to stop planning to transfer actual control of the listed company to a specific target through share transfers and subscriptions.
Analysis
Price Target
No Data
